eCOA, eSource & Clinical Trials Market is envisaged to register a CAGR of ~14% through 2029

The latest Fact.MR study indicates healthcare facilities, contract research organizations, and educational & research institutes collectively spent ~US$ 1,950 Mn on eCOA, eSource and clinical trials solutions in 2018. The eCOA, eSource & clinical trials market is envisaged to witness substantial traction through 2019, with gains primarily driven by the growing penetration of digitization in healthcare sector and substantial increase in pharma spending on clinical trials.

Rapidly expanding deployment of clinical trial solutions, which contributed to ~40% of the total spending on eCOA, eSource, and clinical trials in 2018, will continue to appeal a widening bandwidth of institutions through 2029, says the report.

Get Sample Copy With Impact Analysis Of COVID-19 Of Market Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4042  

ECOA, eSource & Clinical Trials Market – Scope of Report:

A latest publication by Fact.MR on the global ECOA, eSource & Clinical Trials market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market.

The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market.

The principal aim of the study is to present exclusive information about how the market will perform during the forecast period of 2019-2029.

Important indicators for the successful growth of the ECOA, eSource & Clinical Trials market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in Fact.MR’s study.

This research study can support readers to know the demand for ECOA, eSource & Clinical Trials supplements, and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in ECOA, eSource & Clinical Trials market, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market.

Insights and wisdom presented in this Fact.MR study can be leveraged by shareholders in the market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Stakeholders Eyeing Opportunities through Collaborations

As the healthcare sector delves deeper into advanced technology, a large number of companies have formulated unique strategies to remain unaffected by the curve of change. Several pharmaceutical companies, research organizations and CROs have placed their focus on collaborations, while they embrace digitization to create patient-centric experiences. For instance, Signant Health has launched a partner program to collaborate with Clinical Research Organizations (CROs) that are dedicated towards improving clinical trials using patient-centric technology.

Additionally, Iqvia has recently launched a novel eCOA cloud based technology platform to quantify the patient experience, while increasing efficiency and reducing timelines at the same time.

Get Customization on this Report for Specific Research Solutions:- https://www.factmr.com/connectus/sample?flag=RC&rep_id=4042

Report benefits & key questions answered

• Post covid consumer spending on ECOA, eSource & Clinical Trials: the report also highlights the change in the buying behavior of consumers and shifts in purchasing power, post covid-19. This information will assist the businesses to plan their production and marketing strategies.
• ECOA, eSource & Clinical Trials demand outlook: the market intelligence study reports highlights the factor propelling the demand for ECOA, eSource & Clinical Trials. As per the study, the demand for ECOA, eSource & Clinical Trials will grow through 2029.
• ECOA, eSource & Clinical Trials historical volume analysis: Fact.MR survey report provides insights into the sales registered over the last forecast year 2016 to 2018 and create estimates regarding the sales performance for 2019-2029.
• ECOA, eSource & Clinical Trials consumption by demographics: the report provides consumption by demographics analysis to assist the market players in designing their expansion strategies on the basis of consumption pattern of the customers.

ECOA, eSource & Clinical Trials Market Segmentations:

• By Solution Type :

  • eCOA (Electronic Clinical Outcome Assessment)
    • ePROs (Patient Reported Outcomes)
    • ClinROs (Clinician Reported Outcomes)
    • ObsROs (Observer Reported Outcomes)
    • PerfOs (Performance Outcomes)
  • eSource
  • Clinical Trials Solutions
    • Clinical Data Management Systems (CDMS)
    • Clinical Trial Management Systems (CTMS)
    • Randomization and Trial Supply Management Systems (RTMS)
    • Trail Planning and Safety Solutions
  • Electronic Data Capture (EDC)

• By Deployment :

  • On Premise Licensed Enterprise
  • Cloud based (SaaS)

• By End User :

  • Contract Research Organizations
  • Hospitals & Other Healthcare Facilities
  • Pharmaceutical/Biotechnology/Medical Device Companies
  • Educational & Research Institutes

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/4042

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of fortune 1,000 companies trust us for making their most critical decisions. We have offices in us and dublin, whereas our global headquarter is in dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our usp is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com